New User:

-or-
Username:
Password:
Forgot your password?

Stock Market & Financial Investment News

News Breaks
July 28, 2014
08:10 EDTCGOrtho-Clinical Diagnostics, Astute Medical to develope acute kidney injury tests
Ortho-Clinical Diagnostics announced it has entered into a strategic partnership with Astute Medical, under which OCD will become the exclusive commercial partner for the distribution of Astute’s NEPHROCHECK Test and ASTUTE140 Meter in certain markets in Europe and, pending FDA clearance, the United States. On June 30, OCD became an independent, stand-alone diagnostics company with a renewed commitment to expand market reach with differentiated platforms and menus to better serve lab customers. Under the agreement, OCD also receives a semi-exclusive license to develop, manufacture and sell the NEPHROCHECK Test for use on its VITROS line of automated, high-volume testing platforms. In addition, as part of this strategic agreement, OCD has made a $15M equity investment in Astute Medical. Astute will be responsible for manufacturing the Astute NEPHROCHECK Test for use on the ASTUTE140 Meter in all markets and will collaborate with OCD on the sale of the NEPHROCHECK Test.
News For CG From The Last 14 Days
Sign up for a free trial to see the rest of the stories you've been missing.
October 7, 2014
07:09 EDTCGAlternative asset managers shares attractive, says JPMorgan
Subscribe for More Information
October 6, 2014
13:11 EDTCGBlackstone, Carlyle Group mull large deals outside client funds, WSJ says
Subscribe for More Information

Sign up for a free trial to see the rest of the stories you've been missing.

I agree to the theflyonthewall.com disclaimer & terms of use